相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Advances in understanding the pathogenesis of graft-versus-host disease
Robert Zeiser
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Dendritic Cell Regulation of Graft-vs.-Host Disease: Immunostimulation and Tolerance
Hongshuang Yu et al.
FRONTIERS IN IMMUNOLOGY (2019)
Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer's disease
Alicia Lopez et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Chronic graft-versus-host disease: biological insights from preclinical and clinical studies
Kelli P. A. MacDonald et al.
BLOOD (2017)
Extrafollicular CD4+ T-B interactions are sufficient for inducing autoimmune-like chronic graft-versushost disease
Ruishu Deng et al.
NATURE COMMUNICATIONS (2017)
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
Marjolein Soethoudt et al.
NATURE COMMUNICATIONS (2017)
Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production
Jing Du et al.
BLOOD (2017)
Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type 2 Diabetes
Tony Jourdan et al.
DIABETES (2017)
Cannabinoid CB1 and CB2 Receptor Signaling and Bias
Mikkel Soes Ibsen et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
The Cannabinoid Receptor 2 Protects Against Alcoholic Liver Disease Via a Macrophage Autophagy-Dependent Pathway
Timothe Denaes et al.
SCIENTIFIC REPORTS (2016)
Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages
Ping Ke et al.
PLOS ONE (2016)
IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans
Fawaz Alzaid et al.
JCI INSIGHT (2016)
Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis
Resat Cinar et al.
JCI INSIGHT (2016)
Functional Selectivity of CB2 Cannabinoid Receptor Ligands at a Canonical and Noncanonical Pathway
Amey Dhopeshwarkar et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Cutaneous macrophage infiltration in acute GvHD
S. Terakura et al.
BONE MARROW TRANSPLANTATION (2015)
Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites
Caroline Turcotte et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
CB1 cannabinoid receptor antagonist attenuates left ventricular hypertrophy and Akt-mediated cardiac fibrosis in experimental uremia
Chih-Yuan Lin et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Endocannabinoid signaling at the periphery: 50 years after THC
Mauro Maccarrone et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease
Kylie A. Alexander et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage
Lukas Schwab et al.
NATURE MEDICINE (2014)
The Nlrp3 inflammasome regulates acute graft-versus-host disease
Dragana Jankovic et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Thomas A. Wynn et al.
NATURE MEDICINE (2012)
Cannabinoid Receptor Type 2 Functional Variant Influences Liver Damage in Children with Non-Alcoholic Fatty Liver Disease
Francesca Rossi et al.
PLOS ONE (2012)
The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: Implication for a novel molecular biomarker and future therapeutic intervention
Francesca Rossi et al.
PHARMACOLOGICAL RESEARCH (2012)
CB2: Therapeutic target-in-waiting
Brady K. Atwood et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection
Juan G. Zarruk et al.
STROKE (2012)
Advances in graft-versus-host disease biology and therapy
Bruce R. Blazar et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Cyclic AMP-mediated immune regulation - Overview of mechanisms of action in T cells
Randi Mosenden et al.
CELLULAR SIGNALLING (2011)
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura
Francesca Rossi et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Association of the Cannabinoid Receptor 2 (CB2) Gln63Arg Polymorphism with Indices of Liver Damage in Obese Children: An Alternative Way to Highlight the CB2 Hepatoprotective Properties
Francesca Rossi et al.
HEPATOLOGY (2011)
Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease
Sreemanti Basu et al.
IMMUNOLOGIC RESEARCH (2011)
Targeting Cannabinoid Receptors as a Novel Approach in the Treatment of Graft-versus-Host Disease: Evidence from an Experimental Murine Model
Rupal Pandey et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma
Geoffrey R. Hill et al.
BLOOD (2010)
CB2: a cannabinoid receptor with an identity crisis
Brady K. Atwood et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
The regulation of inflammation by galectin-3
Neil C. Henderson et al.
IMMUNOLOGICAL REVIEWS (2009)
The therapeutic potential of novel cannabinoid receptors
Faith R. Kreitzer et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts
Estrella Garcia-Gonzalez et al.
RHEUMATOLOGY (2009)
Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats
Javier Munoz-Luque et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Functional selectivity through protean and biased agonism: Who steers the ship?
Terry Kenakin
MOLECULAR PHARMACOLOGY (2007)
Cyclic adenosine monophosphate is a key component of regulatory T cell mediated suppression
Tobias Bopp et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
The myofibroblast - One function, multiple origins
Boris Hinz et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells
Katarzyna Maresz et al.
NATURE MEDICINE (2007)
Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli
K Maresz et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
S Steffens et al.
NATURE (2005)
Antifibrogenic role of the cannabinoid receptor CB2 in the liver
B Julien et al.
GASTROENTEROLOGY (2005)
分享论文
